Literature DB >> 9313765

Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY.

H Furuta1, N Iwasaki, N Oda, Y Hinokio, Y Horikawa, K Yamagata, N Yano, J Sugahiro, M Ogata, H Ohgawara, Y Omori, Y Iwamoto, G I Bell.   

Abstract

Hepatocyte nuclear factor-4 alpha (HNF-4 alpha) is a member of the nuclear receptor superfamily, a class of ligand-activated transcription factors. A nonsense mutation in the gene encoding this transcription factor was recently found in a white family with one form of maturity-onset diabetes of the young, MODY1. Here, we report the exon-intron organization and partial sequence of the human HNF-4 alpha gene. In addition, we have screened the 12 exons, flanking introns and minimal promoter region for mutations in a group of 57 unrelated Japanese subjects with early-onset NIDDM/MODY of unknown cause. Eight nucleotide substitutions were noted, of which one resulted in the mutation of a conserved arginine residue, Arg127 (CGG)-->Trp (TGG) (designated R127W), located in the T-box, a region of the protein that may play a role in HNF-4 alpha dimerization and DNA binding. This mutation was not found in 214 unrelated nondiabetic subjects (53 Japanese, 53 Chinese, 51 white, and 57 African-American). The R127W mutation was only present in three of five diabetic members in this family, indicating that it is not the only cause of diabetes in this family. The remaining seven nucleotide substitutions were located in the proximal promoter region and introns. They are not predicted to affect the transcription of the gene or mRNA processing and represent polymorphisms and rare variants. The results suggest that mutations in the HNF-4 alpha gene may cause early-onset NIDDM/MODY in Japanese but they are less common than mutations in the HNF-1 alpha/MODY3 gene. The information on the sequence of the HNF-4 alpha gene and its promoter region will facilitate the search for mutations in other populations and studies of the role of this gene in determining normal pancreatic beta-cell function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9313765     DOI: 10.2337/diacare.46.10.1652

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  22 in total

1.  Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1.

Authors:  F M Sladek; M D Ruse; L Nepomuceno; S M Huang; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  The activity of the activation function 2 of the human hepatocyte nuclear factor 4 (HNF-4alpha) is differently modulated by F domains from various origins.

Authors:  L Suaud; P Formstecher; B Laine
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 3.  Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networks.

Authors:  Jean-Philippe Babeu; François Boudreau
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

4.  Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha.

Authors:  S Pruhova; J Ek; J Lebl; Z Sumnik; F Saudek; M Andel; O Pedersen; T Hansen
Journal:  Diabetologia       Date:  2003-01-08       Impact factor: 10.122

Review 5.  The role of HNF4A variants in the risk of type 2 diabetes.

Authors:  Karen L Mohlke; Michael Boehnke
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

6.  The position of premature termination codons in the hepatocyte nuclear factor -1 beta gene determines susceptibility to nonsense-mediated decay.

Authors:  L W Harries; Coralie Bingham; Christine Bellanne-Chantelot; A T Hattersley; Sian Ellard
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

7.  Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection.

Authors:  E R Pearson; S Pruhova; C J Tack; A Johansen; H A J Castleden; P J Lumb; A S Wierzbicki; P M Clark; J Lebl; O Pedersen; S Ellard; T Hansen; A T Hattersley
Journal:  Diabetologia       Date:  2005-04-14       Impact factor: 10.122

8.  Helping nephrologists find answers: hyperinsulinism and tubular dysfunction: Answers.

Authors:  Laura Betcherman; Mathieu Lemaire; Christoph Licht; David Chitayat; Jennifer Harrington; Damien Noone
Journal:  Pediatr Nephrol       Date:  2019-09-16       Impact factor: 3.714

9.  Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs.

Authors:  S Ghosh; R M Watanabe; E R Hauser; T Valle; V L Magnuson; M R Erdos; C D Langefeld; J Balow; D S Ally; K Kohtamaki; P Chines; G Birznieks; H S Kaleta; A Musick; C Te; J Tannenbaum; W Eldridge; S Shapiro; C Martin; A Witt; A So; J Chang; B Shurtleff; R Porter; K Kudelko; A Unni; L Segal; R Sharaf; J Blaschak-Harvan; J Eriksson; T Tenkula; G Vidgren; C Ehnholm; E Tuomilehto-Wolf; W Hagopian; T A Buchanan; J Tuomilehto; R N Bergman; F S Collins; M Boehnke
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

10.  An array of binding sites for hepatocyte nuclear factor 4 of high and low affinities modulates the liver-specific enhancer for the human alpha1-microglobulin/bikunin precursor.

Authors:  P Rouet; G Raguenez; P Ruminy; J P Salier
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.